Pagson Bio-Chem Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 22-12-2024
- Paid Up Capital ₹ 1.00 M
as on 22-12-2024
- Company Age 21 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.00 M
as on 22-12-2024
- Satisfied Charges ₹ 1.46 Cr
as on 22-12-2024
About Pagson Bio-Chem
The Company is engaged in the Musical Instruments Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹9.00 M. The company has closed loans amounting to ₹1.46 Cr, as per Ministry of Corporate Affairs (MCA) records.
Manish Pagar, Nitinkumar Pagar, and Mayur Pagar serve as directors at the Company.
- CIN/LLPIN
U24121GJ2003PTC042400
- Company No.
042400
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 May 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pagson Bio-Chem?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mayur Pagar  | Director | 20-May-2003 | Current |
| Manish Pagar | Director | 12-Jan-2015 | Current |
| Nitinkumar Pagar | Director | 20-May-2003 | Current |
Financial Performance of Pagson Bio-Chem.
Pagson Bio-Chem Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Pagson Bio-Chem?
In 2017, Pagson Bio-Chem had a promoter holding of 60.00% and a public holding of 40.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pagson Pest Control Private LimitedActive 17 years 11 monthsManish Pagar and Mayur Pagar are mutual person
Pagson Chemicals Private LimitedActive 19 years 7 monthsManish Pagar, Nitinkumar Pagar and 1 more are mutual person
Charges (Loans)
₹9.00 M
₹14.60 M
Charges Breakdown by Lending Institutions
- Others : 0.90 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jun 2016 | Others | ₹9.00 M | Open |
| 12 Sep 2012 | Bank Of Baroda | ₹7.30 M | Satisfied |
| 05 Sep 2012 | Bank Of Baroda | ₹7.30 M | Satisfied |
How Many Employees Work at Pagson Bio-Chem?
Unlock and access historical data on people associated with Pagson Bio-Chem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pagson Bio-Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pagson Bio-Chem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
